BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

833 related articles for article (PubMed ID: 26208579)

  • 21. The importance of pre-operative needle core breast biopsy results on resected tissue volume, margin status, and cosmesis.
    Polat AV; Soran A; Andacoglu O; Kamali Polat A; McGuire K; Diego E; Johnson R
    J BUON; 2013; 18(3):601-7. PubMed ID: 24065470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical series of oncoplastic mastopexy to optimize cosmesis of large-volume resections for breast conservation.
    Bong J; Parker J; Clapper R; Dooley W
    Ann Surg Oncol; 2010 Dec; 17(12):3247-51. PubMed ID: 20549563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Neoadjuvant Chemotherapy on Margin Re-excision in Breast-Conserving Surgery.
    Devane LA; Baban CK; O'Doherty A; Quinn C; McDermott EW; Prichard RS
    World J Surg; 2020 May; 44(5):1547-1551. PubMed ID: 32002582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.
    Mukhtar RA; Wong J; Piper M; Zhu Z; Fahrner-Scott K; Mamounas M; Sbitany H; Alvarado M; Foster R; Ewing C; Esserman L
    Ann Surg Oncol; 2018 Oct; 25(11):3165-3170. PubMed ID: 30054826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort Analysis.
    De Lorenzi F; Loschi P; Bagnardi V; Rotmensz N; Hubner G; Mazzarol G; Orecchia R; Galimberti V; Veronesi P; Colleoni MA; Toesca A; Peradze N; Mario R
    Ann Surg Oncol; 2016 Jun; 23(6):1852-9. PubMed ID: 26842491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncoplastic breast conserving surgery is associated with a lower rate of surgical site complications compared to standard breast conserving surgery.
    Crown A; Scovel LG; Rocha FG; Scott EJ; Wechter DG; Grumley JW
    Am J Surg; 2019 Jan; 217(1):138-141. PubMed ID: 30049436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
    Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
    J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Preoperative MRI Workup Affect Mastectomy Rates and/or Re-excision Rates in Patients with Newly Diagnosed Breast Carcinoma? A Retrospective Review.
    Patel BK; Shah NA; Galgano SJ; Newell M; Wang Z; Chen Z; D'Orsi CJ
    Breast J; 2015; 21(6):604-9. PubMed ID: 26387498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
    Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of appropriate short-term mammographic surveillance in patients who undergo breast-conserving Surgery (BCS).
    Gunia SR; Merrigan TL; Poulton TB; Mamounas EP
    Ann Surg Oncol; 2012 Oct; 19(10):3139-43. PubMed ID: 22872291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aesthetic and functional outcome after breast conserving surgery - Comparison between conventional and oncoplastic resection.
    Ojala K; Meretoja TJ; Leidenius MH
    Eur J Surg Oncol; 2017 Apr; 43(4):658-664. PubMed ID: 28040314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reexcision for positive margins in breast cancer: A predictive score of residual disease.
    Mimouni M; Lecuru F; Rouzier R; Lotersztajn N; Heitz D; Cohen J; Fauconnier A; Huchon C
    Surg Oncol; 2015 Sep; 24(3):129-35. PubMed ID: 26298198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of consensus guidelines for breast-conserving surgery in patients with ductal carcinoma in situ.
    Tremelling A; Aft RL; Cyr AE; Gillanders WE; Glover-Collins K; Herrmann V; Margenthaler JA
    Cancer Rep (Hoboken); 2022 May; 5(5):e1502. PubMed ID: 34245135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgeon Variability and Factors Predicting for Reoperation Following Breast-Conserving Surgery.
    Valero MG; Mallory MA; Losk K; Tukenmez M; Hwang J; Camuso K; Bunnell C; King T; Golshan M
    Ann Surg Oncol; 2018 Sep; 25(9):2573-2578. PubMed ID: 29786129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of re-excision and conversion to mastectomy after breast-conserving surgery with or without oncoplastic surgery: a nationwide population-based study.
    Heeg E; Jensen MB; Hölmich LR; Bodilsen A; Tollenaar RAEM; Laenkholm AV; Offersen BV; Ejlertsen B; Mureau MAM; Christiansen PM
    Br J Surg; 2020 Dec; 107(13):1762-1772. PubMed ID: 32761931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MarginProbe© reduces the rate of re-excision following breast conserving surgery for breast cancer.
    Blohmer JU; Tanko J; Kueper J; Groß J; Völker R; Machleidt A
    Arch Gynecol Obstet; 2016 Aug; 294(2):361-7. PubMed ID: 26796680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy.
    Jia H; Jia W; Yang Y; Li S; Feng H; Liu J; Rao N; Jin L; Wu J; Gu R; Zhu L; Chen K; Deng H; Zeng Y; Liu Q; Song E; Su F
    World J Surg Oncol; 2014 Sep; 12():289. PubMed ID: 25241216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor margins that lead to reoperation in breast cancer: A retrospective register study of 4,489 patients.
    Lepomäki M; Karhunen-Enckell U; Tuominen J; Kronqvist P; Oksala N; Murtola T; Roine A
    J Surg Oncol; 2022 Mar; 125(4):577-588. PubMed ID: 34779520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is postexcision, preradiation mammogram necessary in patients after breast-conserving surgery with negative margins.
    Adkisson CD; McLaughlin SA; Vallow LA; Heckman MG; Diehl NN; Bagaria SP; Howe N; Gibson T; Pockaj B
    Ann Surg Oncol; 2013 Oct; 20(10):3205-11. PubMed ID: 23975292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
    Wang K; Zhu GQ; Shi Y; Li ZY; Zhang X; Li HY
    Clin Breast Cancer; 2019 Feb; 19(1):e101-e115. PubMed ID: 30502219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.